The Chinese Cancer Intervention Market Should Reach $46.7 Billion in 2017 and $89.3 Billion by 2022, at a CAGR of 13.8% through 2022

The Chinese Cancer Intervention Market Should Reach $46.7 Billion in 2017 and $89.3 Billion by 2022, at a CAGR of 13.8% through 2022

The scope of the report includes cancer intervention applications, industries, markets, and companies in China. The markets for cancer intervention are given for the years 2016, 2017 and 2022.

The Chinese cancer intervention market includes two major segments: cancer treatment and cancer diagnosis and detection. Each major segment will be further divided and discussed by technology, drug type, end user, etc.

In this report, China is referred to as Mainland China. It does not include Hong Kong, Macao and Taiwan. Mainland China has a total of 31 province-level regions, including 22 provinces, four province-level municipalities (cities), and five province-level autonomous regions. Important geographic markets will be discussed, including Beijing, Shanghai and others.

Report Includes

Key Topics Covered:

1: Introduction

2: Summary and Highlights

3: Market and Technology Background

4: Market Breakdown by Technology Type

5: Market Breakdown by Product

6: Market Breakdown by End Use

7: Market Breakdown by Region

8: Analysis of Market Opportunities

9: Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/chsl29/the_chinese

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716